• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1例在伊匹单抗-纳武单抗联合治疗期间因免疫相关不良事件导致关节炎和结肠炎的转移性肾细胞癌病例]

[A Case of Metastatic Renal Cell Carcinoma with Arthritis and Colitis Due to Immune-Related Adverse Events During Ipilimumab-Nivolumab Combination Therapy].

作者信息

Toyoshima Moe, Ikarashi Daiki, Tsuboi Hiroyuki, Moriwaka Makoto, Tamada Shinji, Matsuura Tomohiko, Maekawa Shigekatsu, Kato Renpei, Kanehira Mitsugu, Takata Ryo, Sugimura Jun, Obara Wataru

机构信息

The Department of Urology, Iwate Medical University.

The Department of Rehabilitation, Iwate Medical University Hospital.

出版信息

Hinyokika Kiyo. 2023 Aug;69(8):227-232. doi: 10.14989/ActaUrolJap_69_8_227.

DOI:10.14989/ActaUrolJap_69_8_227
PMID:37667600
Abstract

A 73-year-old man with renal cell carcinoma underwent a left-sided open radical nephrectomy at our center. The pathological diagnosis was Fuhrman Grade 2, stage pT3a, clear cell renal cell carcinoma. A follow-up computed tomography (CT) scan revealed lung metastases 9 months after the surgery. The patient was started on ipilimumab with nivolumab combination therapy; however, after two cycles of administration, he developed arthralgia and swelling of the knee. Furthermore, he developed diarrhea almost simultaneously, resulting in the interruption of the ipilimumab plus nivolumab treatment. We diagnosed arthritis and colitis with immune-related adverse events (irAE) and initiated steroid therapy with rehabilitation. His condition improved dramatically, and nivolumab treatment could be resumed after 3 months of treatment interruption.

摘要

一名73岁的肾细胞癌男性患者在我们中心接受了左侧开放性根治性肾切除术。病理诊断为富尔曼2级,pT3a期,透明细胞肾细胞癌。术后9个月的随访计算机断层扫描(CT)显示有肺转移。患者开始接受伊匹单抗联合纳武单抗治疗;然而,在两个疗程的给药后,他出现了关节痛和膝盖肿胀。此外,他几乎同时出现腹泻,导致伊匹单抗加纳武单抗治疗中断。我们诊断为关节炎和结肠炎伴免疫相关不良事件(irAE),并开始使用类固醇治疗并进行康复治疗。他的病情显著改善,在治疗中断3个月后可以恢复纳武单抗治疗。

相似文献

1
[A Case of Metastatic Renal Cell Carcinoma with Arthritis and Colitis Due to Immune-Related Adverse Events During Ipilimumab-Nivolumab Combination Therapy].[1例在伊匹单抗-纳武单抗联合治疗期间因免疫相关不良事件导致关节炎和结肠炎的转移性肾细胞癌病例]
Hinyokika Kiyo. 2023 Aug;69(8):227-232. doi: 10.14989/ActaUrolJap_69_8_227.
2
[A Case of Metachronous Occurrence of Interstitial Pneumonitis and Hypophysitis Following Nivolumab Plus Ipilimumab for Metastatic Renal Cell Carcinoma].[一例纳武利尤单抗联合伊匹木单抗治疗转移性肾细胞癌后间质性肺炎和垂体炎异时发生的病例]
Hinyokika Kiyo. 2021 Jun;67(6):239-243. doi: 10.14989/ActaUrolJap_67_6_239.
3
Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report.免疫检查点抑制剂治疗转移性肾细胞癌后发生心肌炎的病例报告:免疫相关不良事件。
J Med Case Rep. 2021 Oct 15;15(1):508. doi: 10.1186/s13256-021-03097-6.
4
Prognostic Impact of Early Treatment Interruption of Nivolumab Plus Ipilimumab Due to Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Multi-Institution Retrospective Study.一线治疗转移性肾细胞癌时因免疫相关不良事件导致纳武利尤单抗联合伊匹单抗早期治疗中断的预后影响:一项多机构回顾性研究。
Target Oncol. 2021 Jul;16(4):493-502. doi: 10.1007/s11523-021-00825-2. Epub 2021 Jun 26.
5
Prognostic impact of immune-related adverse events in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.纳武利尤单抗联合伊匹单抗治疗转移性肾细胞癌的免疫相关不良事件的预后影响。
Urol Oncol. 2021 Oct;39(10):735.e9-735.e16. doi: 10.1016/j.urolonc.2021.05.012. Epub 2021 Jun 22.
6
Immune-mediated colitis secondary to treatment with nivolumab-ipilimumab in a patient with stage IV kidney cancer: what do we do when corticosteroids fail?免疫介导的结肠炎继发于纳武利尤单抗-伊匹单抗治疗 IV 期肾癌患者:当皮质类固醇治疗失败时我们该怎么办?
Rev Esp Enferm Dig. 2022 Sep;114(9):554-555. doi: 10.17235/reed.2022.8632/2022.
7
[INTERSTITIAL NEPHRITIS CAUSED BY IPILIMUMAB AND NIVOLUMAB COMBINATION THERAPY FOR ADVANCED RENAL CELL CARCINOMA: A CASE REPORT].[伊匹单抗和纳武单抗联合治疗晚期肾细胞癌引起的间质性肾炎:一例报告]
Nihon Hinyokika Gakkai Zasshi. 2021;112(2):109-112. doi: 10.5980/jpnjurol.112.109.
8
Three Cases of Nivolumab Plus Ipilimumab Therapy in Haemodialysis Patients With Metastatic Renal Cell Carcinoma.三例血液透析患者转移性肾细胞癌接受纳武利尤单抗联合伊匹单抗治疗。
In Vivo. 2021 Nov-Dec;35(6):3585-3589. doi: 10.21873/invivo.12663.
9
[A Case of Pappilary Renal Cell Caircinoma which Responded Well to the Combination Therapy of Ipilimumab and Nivolumab --A CASE REPORT-].[一例对伊匹木单抗和纳武单抗联合治疗反应良好的乳头状肾细胞癌——病例报告]
Hinyokika Kiyo. 2022 Apr;68(4):107-111. doi: 10.14989/ActaUrolJap_68_4_107.
10
Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma.纳武利尤单抗联合伊匹单抗治疗晚期肾细胞癌患者行细胞减瘤性肾切除术的影响。
Anticancer Res. 2022 May;42(5):2727-2735. doi: 10.21873/anticanres.15751.